Use of Extracellular Vesicles (EV) for Knee Osteoarthrosis
Recruiting
Phase 1
Interventional Study
Knee Osteoarthrosis
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
At a Glance
- Age
- 42 – 75
- Sex
- Any
- Trial phase
- Phase 1
- Study type
- Interventional
- Purpose
- Treatment
- Participants needed
- 50 (estimated)
- Sponsor
- University of Jordan · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
Extracellular vesicles (EV) will be injected in patients diagnosed with Knee osteoarthrosis
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* Severe KOA stage III or IV by Laurance \& Kellgren staging as judged by Posterioranterior (PA) Xray of the knee joint.
* Willing to participate by signing the informed consent
Exclusion Criteria:
* Sublaxation beyond 20 degrees of the bones of the knee joint
* Oral anticoagu…
Contacts